Skip to main content
Fig. 2 | Journal of Pharmaceutical Policy and Practice

Fig. 2

From: Price and reimbursement of advanced therapeutic medicinal products in Europe: are assessment and appraisal diverging from expert recommendations?

Fig. 2

Funding of clinical trials with ATMPs. The current ATMP pipeline analysed retrieved clinical trials on ATMPs from the clinicaltrials.gov database and selecting with the following inclusion criteria: interventional studies, phase II/, II/III and III studies, ongoing or completed studies, 1/07/2017–1/7/2019 as temporal limitation, and Directive 2001/83/EC plus Committee for Advanced Therapies algorithm used as definition of “ATMP”. Of 249 clinical trials included in the final analysis (after exclusion of duplicates and those not targeting ATMPs), 93 (37%) were funded by companies, 114 (46%) through other sources, and 42 (17%) were co-funded by companies and others

Back to article page